Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

NIR light therapy may effectively treat eye diseases and improve brain function without side effects.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Stem cell therapies are advancing quickly with new technologies and need supportive regulations for clinical use.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

Drug repurposing shows promise for treating many medical conditions.

Fractional infrared technology is effective and safe for treating cervical laxity.

Erlotinib can cause excessive eyelash growth.

GV-350 improves hair growth and quality of life in iron-deficient women without side effects.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

OXTR agonists may promote hair growth and be effective for treating hair loss.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Aumolertinib effectively controls lung cancer and improves quality of life.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

The E2 protein affects gene activity in hair follicles of mice.

Etanercept may not prevent alopecia areata from coming back.

The new drug delivery system improves exemestane's absorption and effectiveness.